Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures (0.37%), Hang Seng Futures +0.82%, ASX SPI 200 +0.07%, S&P Futures +0.08%

Jan 15 ,2026

  • Synopsis:

    • Asian markets set for mixed start to Friday trade. Futures signaling opening gains in Hong Kong while Japan futures ended slightly lower. ASX flat in initial trade. Australian bonds weakening after Treasuries curve bear flattened. FX markets steady with yen and Korean won stabilizing following run of declines. Crude flat following earlier sell-off after Trump dialed back hawkish Iran rhetoric. Gold unchanged. Bitcoin little changed after pulling back from two-month high.

    • US and Taiwan reached trade deal that largely mirrored press leaks with tariff rate dropping to 15% from 20% and Taiwan to increase US investment by $500B ($250B in direct funding and $250B in credit guarantees). Bloomberg source said TSMC (2330.TT) to build at least four more chip factories in Arizona. TSMC rallied 4% in US following strong Q4 results, where margin beat, Q1 revenue guidance, upgraded capex estimate and upbeat AI commentary were among highlights. Results helped underpin AI sentiment with semis and AI-linked names among outperformers.

    • Ahead of next week's meeting, Bloomberg sources said BOJ officials monitoring impact of yen weakness, particularly how currency will affect underlying inflation, and implications for policy. While BOJ expected to leave rates on hold next week, yen weakness becoming more important policy consideration with officials mindful that it could prompt pull forward of future rate hikes. Yen has stabilized in past two sessions after approaching 18-month low against dollar, following repeated verbal warnings from Finance Minister Katayama.

    • Late Thursday, PBOC announced structural monetary policy tools will see 25 bp rate cuts. Central bank said rate cuts aimed at addressing economic weak links and market did register much of a reaction. Deputy Governor Zou added there is still some space to reduce RRR and policy rates this year. Comes after latest lending figures showed credit and loan growth picked up in December, signaling permeation of CNY500B in new financial instruments unveiled in September to accelerate investment projects.

  • Pre-open Company News:

    • 3993.HK -- CMOC Group guides FY net income attributable CNY20.0-20.8B vs FactSet CNY19.79B [22 est, CNY17.74-20.87B]

    • 543940.IN -- Jio Financial Services reports Q3 consolidated EPS INR0.42 vs year-ago INR0.46

    • 8053.JP -- Sumitomo upgraded to overweight from neutral at JPMorgan

    • BS6.SP -- Yangzijiang Shipbuilding (Holdings) downgraded to hold from buy at HSBC

    • 2899.HK -- Jinduicheng Molybdenum acquires 24% stake in Jinsha Molybdenum from Zijin Mining for CNY1.73B cash

    • 532321.IN -- Zydus Lifesciences completes acquisition of Agenus's biologics manufacturing facilities; deal was announced 3-Jun

    • 1952.HK -- Transcript Intelligence: Everest Medicines at J.P. Morgan Healthcare Conference

    • 000723.CH -- Shanxi Meijin Energy guides FY net income attributable (CNY0.85-1.25B) vs year-ago (CNY1.14B)

    • 500850.IN -- Indian Hotels Company to acquire 51% stake in Brij Hospitality for up to INR2.25B cash

    • 532523.IN -- Transcript Intelligence: Biocon at J.P. Morgan Healthcare Conference

    • 81.HK -- China Overseas Grand Oceans Group initiated buy at Kaiyuan Securities (timing uncertain)

    • UMI.BB -- EU clears HS HYOSUNG ADVANCED MATERIALS' acquisition of 80% of Umicore's Extra Mile

    • AGEN -- Agenus announces closing of $141M strategic collaboration with Zydus Lifesciences to advance BOT+BAL and strengthen U.S. manufacturing readiness

    • 300999.CH -- Yihai Kerry Arawana Holdings sells its 50% stake in two Kellogg's China units to Mars Wrigley Confectionery (China) for $65M (CNY453.3M) cash

  • On Deck:

    • Japan:

      • Economic:

        • 13:30 JST: Retail Sales NSA Y/Y (Final); consensus

    • India:

      • Earnings:

        • Federal Bank Ltd (India) (500469.IN), Poonawalla Fincorp (524000.IN), Tech Mahindra (532755.IN), Central Bank of India (532885.IN), Himadri Speciality Chemical (500184.IN), Reliance Industries (500325.IN), Jindal SAW (500378.IN), JB Chemicals & Pharmaceuticals (506943.IN), Sobha Ltd (532784.IN), L&T Finance (533519.IN)

    • Malaysia:

      • Economic:

        • 23:00 EST: GDP NSA Y/Y (Preliminary); consensus +5%

  • Market Data:

    • Gold (Feb 26): ($8.80) or (0.19%) to $4614.90

    • WTI Crude (Feb 26): ($0.05) or (0.08%) to $59.14

    • $-¥: +0.18 or +0.11% to 158.6390

    • $-KRW: +1.77 or +0.12% to 1468.9400

    • A$-$: +0.00 or +0.23% to 0.6700

    • $-INR: +0.11 or +0.13% to 90.3615

    • $-CNY: (0.01) or (0.12%) to 6.9654

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE